nodes	percent_of_prediction	percent_of_DWPC	metapath
Cilostazol—CYP3A5—Gefitinib—lung cancer	0.0401	0.0615	CbGbCtD
Cilostazol—CYP3A5—Teniposide—lung cancer	0.0389	0.0597	CbGbCtD
Cilostazol—CYP2C19—Gefitinib—lung cancer	0.0324	0.0496	CbGbCtD
Cilostazol—CYP2C19—Teniposide—lung cancer	0.0314	0.0481	CbGbCtD
Cilostazol—CYP3A7-CYP3A51P—Paclitaxel—lung cancer	0.029	0.0444	CbGbCtD
Cilostazol—CYP3A7—Paclitaxel—lung cancer	0.029	0.0444	CbGbCtD
Cilostazol—CYP3A7—Irinotecan—lung cancer	0.0286	0.0438	CbGbCtD
Cilostazol—CYP3A7-CYP3A51P—Irinotecan—lung cancer	0.0286	0.0438	CbGbCtD
Cilostazol—CYP2D6—Gefitinib—lung cancer	0.0246	0.0377	CbGbCtD
Cilostazol—CYP3A5—Crizotinib—lung cancer	0.0246	0.0377	CbGbCtD
Cilostazol—CYP3A5—Erlotinib—lung cancer	0.0237	0.0364	CbGbCtD
Cilostazol—CYP3A5—Paclitaxel—lung cancer	0.0217	0.0333	CbGbCtD
Cilostazol—CYP3A5—Irinotecan—lung cancer	0.0214	0.0329	CbGbCtD
Cilostazol—CYP3A7—Docetaxel—lung cancer	0.0209	0.0321	CbGbCtD
Cilostazol—CYP3A7-CYP3A51P—Docetaxel—lung cancer	0.0209	0.0321	CbGbCtD
Cilostazol—CYP2D6—Vinorelbine—lung cancer	0.019	0.0291	CbGbCtD
Cilostazol—CYP1A2—Erlotinib—lung cancer	0.0177	0.0271	CbGbCtD
Cilostazol—CYP3A5—Etoposide—lung cancer	0.0172	0.0263	CbGbCtD
Cilostazol—CYP3A4—Topotecan—lung cancer	0.0171	0.0262	CbGbCtD
Cilostazol—CYP3A5—Docetaxel—lung cancer	0.0157	0.0241	CbGbCtD
Cilostazol—CYP3A4—Gefitinib—lung cancer	0.0157	0.024	CbGbCtD
Cilostazol—CYP3A4—Teniposide—lung cancer	0.0152	0.0233	CbGbCtD
Cilostazol—CYP2D6—Erlotinib—lung cancer	0.0146	0.0223	CbGbCtD
Cilostazol—CYP1A2—Etoposide—lung cancer	0.0128	0.0196	CbGbCtD
Cilostazol—CYP3A4—Vinorelbine—lung cancer	0.0121	0.0185	CbGbCtD
Cilostazol—CYP2D6—Vinblastine—lung cancer	0.0117	0.0179	CbGbCtD
Cilostazol—CYP3A4—Crizotinib—lung cancer	0.00959	0.0147	CbGbCtD
Cilostazol—CYP3A4—Erlotinib—lung cancer	0.00925	0.0142	CbGbCtD
Cilostazol—CYP3A4—Paclitaxel—lung cancer	0.00847	0.013	CbGbCtD
Cilostazol—CYP3A4—Irinotecan—lung cancer	0.00836	0.0128	CbGbCtD
Cilostazol—CYP3A4—Vinblastine—lung cancer	0.00743	0.0114	CbGbCtD
Cilostazol—CYP2D6—Doxorubicin—lung cancer	0.00718	0.011	CbGbCtD
Cilostazol—CYP3A4—Etoposide—lung cancer	0.00669	0.0103	CbGbCtD
Cilostazol—CYP3A4—Docetaxel—lung cancer	0.00612	0.00939	CbGbCtD
Cilostazol—CYP3A4—Doxorubicin—lung cancer	0.00457	0.007	CbGbCtD
Cilostazol—Anaemia—Docetaxel—lung cancer	0.000106	0.000416	CcSEcCtD
Cilostazol—Anorexia—Paclitaxel—lung cancer	0.000105	0.000413	CcSEcCtD
Cilostazol—Hypotension—Etoposide—lung cancer	0.000105	0.000413	CcSEcCtD
Cilostazol—Gastritis—Doxorubicin—lung cancer	0.000105	0.000413	CcSEcCtD
Cilostazol—Pain—Cisplatin—lung cancer	0.000105	0.000412	CcSEcCtD
Cilostazol—Stevens-Johnson syndrome—Methotrexate—lung cancer	0.000105	0.000411	CcSEcCtD
Cilostazol—Vomiting—Vinorelbine—lung cancer	0.000104	0.00041	CcSEcCtD
Cilostazol—Body temperature increased—Gemcitabine—lung cancer	0.000104	0.000409	CcSEcCtD
Cilostazol—Rash—Vinorelbine—lung cancer	0.000104	0.000406	CcSEcCtD
Cilostazol—Dermatitis—Vinorelbine—lung cancer	0.000103	0.000406	CcSEcCtD
Cilostazol—Hypotension—Paclitaxel—lung cancer	0.000103	0.000405	CcSEcCtD
Cilostazol—Headache—Vinorelbine—lung cancer	0.000103	0.000404	CcSEcCtD
Cilostazol—Syncope—Docetaxel—lung cancer	0.000103	0.000404	CcSEcCtD
Cilostazol—Conjunctivitis—Methotrexate—lung cancer	0.000103	0.000403	CcSEcCtD
Cilostazol—Asthma—Doxorubicin—lung cancer	0.000103	0.000403	CcSEcCtD
Cilostazol—Influenza—Doxorubicin—lung cancer	0.000103	0.000403	CcSEcCtD
Cilostazol—Leukopenia—Docetaxel—lung cancer	0.000103	0.000403	CcSEcCtD
Cilostazol—Palpitations—Docetaxel—lung cancer	0.000101	0.000398	CcSEcCtD
Cilostazol—Feeling abnormal—Cisplatin—lung cancer	0.000101	0.000397	CcSEcCtD
Cilostazol—Paraesthesia—Etoposide—lung cancer	0.000101	0.000397	CcSEcCtD
Cilostazol—Haematuria—Methotrexate—lung cancer	0.000101	0.000396	CcSEcCtD
Cilostazol—Loss of consciousness—Docetaxel—lung cancer	0.000101	0.000395	CcSEcCtD
Cilostazol—Musculoskeletal discomfort—Paclitaxel—lung cancer	0.000101	0.000395	CcSEcCtD
Cilostazol—Dyspnoea—Etoposide—lung cancer	0.0001	0.000394	CcSEcCtD
Cilostazol—Cough—Docetaxel—lung cancer	0.0001	0.000393	CcSEcCtD
Cilostazol—Angina pectoris—Doxorubicin—lung cancer	0.0001	0.000393	CcSEcCtD
Cilostazol—Hepatobiliary disease—Methotrexate—lung cancer	0.0001	0.000392	CcSEcCtD
Cilostazol—Insomnia—Paclitaxel—lung cancer	9.99e-05	0.000392	CcSEcCtD
Cilostazol—Epistaxis—Methotrexate—lung cancer	9.98e-05	0.000391	CcSEcCtD
Cilostazol—Paraesthesia—Paclitaxel—lung cancer	9.92e-05	0.000389	CcSEcCtD
Cilostazol—Hypertension—Docetaxel—lung cancer	9.91e-05	0.000388	CcSEcCtD
Cilostazol—Bronchitis—Doxorubicin—lung cancer	9.89e-05	0.000388	CcSEcCtD
Cilostazol—Agranulocytosis—Methotrexate—lung cancer	9.88e-05	0.000387	CcSEcCtD
Cilostazol—Dyspnoea—Paclitaxel—lung cancer	9.85e-05	0.000386	CcSEcCtD
Cilostazol—Decreased appetite—Etoposide—lung cancer	9.8e-05	0.000384	CcSEcCtD
Cilostazol—Arthralgia—Docetaxel—lung cancer	9.77e-05	0.000383	CcSEcCtD
Cilostazol—Chest pain—Docetaxel—lung cancer	9.77e-05	0.000383	CcSEcCtD
Cilostazol—Myalgia—Docetaxel—lung cancer	9.77e-05	0.000383	CcSEcCtD
Cilostazol—Pancytopenia—Doxorubicin—lung cancer	9.76e-05	0.000383	CcSEcCtD
Cilostazol—Nausea—Vinorelbine—lung cancer	9.76e-05	0.000383	CcSEcCtD
Cilostazol—Gastrointestinal disorder—Etoposide—lung cancer	9.73e-05	0.000382	CcSEcCtD
Cilostazol—Dyspepsia—Paclitaxel—lung cancer	9.73e-05	0.000381	CcSEcCtD
Cilostazol—Body temperature increased—Cisplatin—lung cancer	9.72e-05	0.000381	CcSEcCtD
Cilostazol—Asthenia—Irinotecan—lung cancer	9.72e-05	0.000381	CcSEcCtD
Cilostazol—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	9.7e-05	0.00038	CcSEcCtD
Cilostazol—Pain—Etoposide—lung cancer	9.64e-05	0.000378	CcSEcCtD
Cilostazol—Decreased appetite—Paclitaxel—lung cancer	9.61e-05	0.000377	CcSEcCtD
Cilostazol—Haemoglobin—Methotrexate—lung cancer	9.55e-05	0.000374	CcSEcCtD
Cilostazol—Gastrointestinal disorder—Paclitaxel—lung cancer	9.54e-05	0.000374	CcSEcCtD
Cilostazol—Haemorrhage—Methotrexate—lung cancer	9.5e-05	0.000373	CcSEcCtD
Cilostazol—Pollakiuria—Doxorubicin—lung cancer	9.5e-05	0.000372	CcSEcCtD
Cilostazol—Asthenia—Gemcitabine—lung cancer	9.47e-05	0.000371	CcSEcCtD
Cilostazol—Pain—Paclitaxel—lung cancer	9.45e-05	0.000371	CcSEcCtD
Cilostazol—Pharyngitis—Methotrexate—lung cancer	9.43e-05	0.00037	CcSEcCtD
Cilostazol—Oedema—Docetaxel—lung cancer	9.37e-05	0.000367	CcSEcCtD
Cilostazol—Pruritus—Gemcitabine—lung cancer	9.34e-05	0.000366	CcSEcCtD
Cilostazol—Infection—Docetaxel—lung cancer	9.31e-05	0.000365	CcSEcCtD
Cilostazol—Feeling abnormal—Etoposide—lung cancer	9.29e-05	0.000364	CcSEcCtD
Cilostazol—Diarrhoea—Irinotecan—lung cancer	9.27e-05	0.000363	CcSEcCtD
Cilostazol—Pneumonia—Doxorubicin—lung cancer	9.22e-05	0.000361	CcSEcCtD
Cilostazol—Gastrointestinal pain—Etoposide—lung cancer	9.22e-05	0.000361	CcSEcCtD
Cilostazol—Shock—Docetaxel—lung cancer	9.21e-05	0.000361	CcSEcCtD
Cilostazol—Nervous system disorder—Docetaxel—lung cancer	9.19e-05	0.00036	CcSEcCtD
Cilostazol—Thrombocytopenia—Docetaxel—lung cancer	9.17e-05	0.00036	CcSEcCtD
Cilostazol—Tachycardia—Docetaxel—lung cancer	9.14e-05	0.000358	CcSEcCtD
Cilostazol—Feeling abnormal—Paclitaxel—lung cancer	9.11e-05	0.000357	CcSEcCtD
Cilostazol—Skin disorder—Docetaxel—lung cancer	9.1e-05	0.000357	CcSEcCtD
Cilostazol—Stevens-Johnson syndrome—Doxorubicin—lung cancer	9.09e-05	0.000356	CcSEcCtD
Cilostazol—Gastrointestinal pain—Paclitaxel—lung cancer	9.04e-05	0.000354	CcSEcCtD
Cilostazol—Diarrhoea—Gemcitabine—lung cancer	9.03e-05	0.000354	CcSEcCtD
Cilostazol—Erythema multiforme—Methotrexate—lung cancer	8.98e-05	0.000352	CcSEcCtD
Cilostazol—Dizziness—Irinotecan—lung cancer	8.96e-05	0.000351	CcSEcCtD
Cilostazol—Urticaria—Etoposide—lung cancer	8.95e-05	0.000351	CcSEcCtD
Cilostazol—Jaundice—Doxorubicin—lung cancer	8.93e-05	0.00035	CcSEcCtD
Cilostazol—Anorexia—Docetaxel—lung cancer	8.93e-05	0.00035	CcSEcCtD
Cilostazol—Body temperature increased—Etoposide—lung cancer	8.91e-05	0.000349	CcSEcCtD
Cilostazol—Abdominal pain—Etoposide—lung cancer	8.91e-05	0.000349	CcSEcCtD
Cilostazol—Conjunctivitis—Doxorubicin—lung cancer	8.91e-05	0.000349	CcSEcCtD
Cilostazol—Urinary tract infection—Doxorubicin—lung cancer	8.91e-05	0.000349	CcSEcCtD
Cilostazol—Tinnitus—Methotrexate—lung cancer	8.86e-05	0.000347	CcSEcCtD
Cilostazol—Asthenia—Cisplatin—lung cancer	8.83e-05	0.000346	CcSEcCtD
Cilostazol—Cardiac disorder—Methotrexate—lung cancer	8.82e-05	0.000346	CcSEcCtD
Cilostazol—Urticaria—Paclitaxel—lung cancer	8.78e-05	0.000344	CcSEcCtD
Cilostazol—Hypotension—Docetaxel—lung cancer	8.75e-05	0.000343	CcSEcCtD
Cilostazol—Haematuria—Doxorubicin—lung cancer	8.74e-05	0.000343	CcSEcCtD
Cilostazol—Abdominal pain—Paclitaxel—lung cancer	8.74e-05	0.000343	CcSEcCtD
Cilostazol—Body temperature increased—Paclitaxel—lung cancer	8.74e-05	0.000343	CcSEcCtD
Cilostazol—Hepatobiliary disease—Doxorubicin—lung cancer	8.67e-05	0.00034	CcSEcCtD
Cilostazol—Epistaxis—Doxorubicin—lung cancer	8.64e-05	0.000339	CcSEcCtD
Cilostazol—Angiopathy—Methotrexate—lung cancer	8.62e-05	0.000338	CcSEcCtD
Cilostazol—Vomiting—Irinotecan—lung cancer	8.61e-05	0.000338	CcSEcCtD
Cilostazol—Sinusitis—Doxorubicin—lung cancer	8.6e-05	0.000337	CcSEcCtD
Cilostazol—Mediastinal disorder—Methotrexate—lung cancer	8.56e-05	0.000336	CcSEcCtD
Cilostazol—Agranulocytosis—Doxorubicin—lung cancer	8.55e-05	0.000335	CcSEcCtD
Cilostazol—Rash—Irinotecan—lung cancer	8.54e-05	0.000335	CcSEcCtD
Cilostazol—Dermatitis—Irinotecan—lung cancer	8.54e-05	0.000335	CcSEcCtD
Cilostazol—Musculoskeletal discomfort—Docetaxel—lung cancer	8.53e-05	0.000335	CcSEcCtD
Cilostazol—Chills—Methotrexate—lung cancer	8.53e-05	0.000334	CcSEcCtD
Cilostazol—Headache—Irinotecan—lung cancer	8.49e-05	0.000333	CcSEcCtD
Cilostazol—Insomnia—Docetaxel—lung cancer	8.47e-05	0.000332	CcSEcCtD
Cilostazol—Diarrhoea—Cisplatin—lung cancer	8.42e-05	0.00033	CcSEcCtD
Cilostazol—Paraesthesia—Docetaxel—lung cancer	8.41e-05	0.00033	CcSEcCtD
Cilostazol—Vomiting—Gemcitabine—lung cancer	8.39e-05	0.000329	CcSEcCtD
Cilostazol—Dyspnoea—Docetaxel—lung cancer	8.35e-05	0.000327	CcSEcCtD
Cilostazol—Rash—Gemcitabine—lung cancer	8.32e-05	0.000326	CcSEcCtD
Cilostazol—Dermatitis—Gemcitabine—lung cancer	8.31e-05	0.000326	CcSEcCtD
Cilostazol—Haemoglobin—Doxorubicin—lung cancer	8.27e-05	0.000324	CcSEcCtD
Cilostazol—Headache—Gemcitabine—lung cancer	8.27e-05	0.000324	CcSEcCtD
Cilostazol—Rhinitis—Doxorubicin—lung cancer	8.25e-05	0.000323	CcSEcCtD
Cilostazol—Dyspepsia—Docetaxel—lung cancer	8.24e-05	0.000323	CcSEcCtD
Cilostazol—Haemorrhage—Doxorubicin—lung cancer	8.23e-05	0.000323	CcSEcCtD
Cilostazol—Hypoaesthesia—Doxorubicin—lung cancer	8.19e-05	0.000321	CcSEcCtD
Cilostazol—Pharyngitis—Doxorubicin—lung cancer	8.17e-05	0.00032	CcSEcCtD
Cilostazol—Decreased appetite—Docetaxel—lung cancer	8.14e-05	0.000319	CcSEcCtD
Cilostazol—Oedema peripheral—Doxorubicin—lung cancer	8.11e-05	0.000318	CcSEcCtD
Cilostazol—Gastrointestinal disorder—Docetaxel—lung cancer	8.09e-05	0.000317	CcSEcCtD
Cilostazol—Asthenia—Etoposide—lung cancer	8.09e-05	0.000317	CcSEcCtD
Cilostazol—Nausea—Irinotecan—lung cancer	8.05e-05	0.000316	CcSEcCtD
Cilostazol—Pain—Docetaxel—lung cancer	8.01e-05	0.000314	CcSEcCtD
Cilostazol—Back pain—Methotrexate—lung cancer	8e-05	0.000314	CcSEcCtD
Cilostazol—Pruritus—Etoposide—lung cancer	7.97e-05	0.000313	CcSEcCtD
Cilostazol—Asthenia—Paclitaxel—lung cancer	7.93e-05	0.000311	CcSEcCtD
Cilostazol—Nausea—Gemcitabine—lung cancer	7.84e-05	0.000307	CcSEcCtD
Cilostazol—Vomiting—Cisplatin—lung cancer	7.82e-05	0.000307	CcSEcCtD
Cilostazol—Pruritus—Paclitaxel—lung cancer	7.82e-05	0.000307	CcSEcCtD
Cilostazol—Erythema multiforme—Doxorubicin—lung cancer	7.78e-05	0.000305	CcSEcCtD
Cilostazol—Rash—Cisplatin—lung cancer	7.76e-05	0.000304	CcSEcCtD
Cilostazol—Dermatitis—Cisplatin—lung cancer	7.75e-05	0.000304	CcSEcCtD
Cilostazol—Feeling abnormal—Docetaxel—lung cancer	7.72e-05	0.000303	CcSEcCtD
Cilostazol—Diarrhoea—Etoposide—lung cancer	7.71e-05	0.000302	CcSEcCtD
Cilostazol—Ill-defined disorder—Methotrexate—lung cancer	7.67e-05	0.000301	CcSEcCtD
Cilostazol—Tinnitus—Doxorubicin—lung cancer	7.67e-05	0.000301	CcSEcCtD
Cilostazol—Gastrointestinal pain—Docetaxel—lung cancer	7.66e-05	0.0003	CcSEcCtD
Cilostazol—Anaemia—Methotrexate—lung cancer	7.65e-05	0.0003	CcSEcCtD
Cilostazol—Cardiac disorder—Doxorubicin—lung cancer	7.64e-05	0.000299	CcSEcCtD
Cilostazol—Diarrhoea—Paclitaxel—lung cancer	7.56e-05	0.000296	CcSEcCtD
Cilostazol—Angiopathy—Doxorubicin—lung cancer	7.46e-05	0.000293	CcSEcCtD
Cilostazol—Malaise—Methotrexate—lung cancer	7.46e-05	0.000292	CcSEcCtD
Cilostazol—Dizziness—Etoposide—lung cancer	7.45e-05	0.000292	CcSEcCtD
Cilostazol—Vertigo—Methotrexate—lung cancer	7.43e-05	0.000291	CcSEcCtD
Cilostazol—Mediastinal disorder—Doxorubicin—lung cancer	7.42e-05	0.000291	CcSEcCtD
Cilostazol—Abdominal pain—Docetaxel—lung cancer	7.4e-05	0.00029	CcSEcCtD
Cilostazol—Body temperature increased—Docetaxel—lung cancer	7.4e-05	0.00029	CcSEcCtD
Cilostazol—Leukopenia—Methotrexate—lung cancer	7.4e-05	0.00029	CcSEcCtD
Cilostazol—Chills—Doxorubicin—lung cancer	7.38e-05	0.000289	CcSEcCtD
Cilostazol—Dizziness—Paclitaxel—lung cancer	7.31e-05	0.000287	CcSEcCtD
Cilostazol—Nausea—Cisplatin—lung cancer	7.31e-05	0.000287	CcSEcCtD
Cilostazol—Cough—Methotrexate—lung cancer	7.22e-05	0.000283	CcSEcCtD
Cilostazol—Vomiting—Etoposide—lung cancer	7.17e-05	0.000281	CcSEcCtD
Cilostazol—Rash—Etoposide—lung cancer	7.11e-05	0.000279	CcSEcCtD
Cilostazol—Dermatitis—Etoposide—lung cancer	7.1e-05	0.000278	CcSEcCtD
Cilostazol—Headache—Etoposide—lung cancer	7.06e-05	0.000277	CcSEcCtD
Cilostazol—Flatulence—Doxorubicin—lung cancer	7.06e-05	0.000277	CcSEcCtD
Cilostazol—Chest pain—Methotrexate—lung cancer	7.04e-05	0.000276	CcSEcCtD
Cilostazol—Arthralgia—Methotrexate—lung cancer	7.04e-05	0.000276	CcSEcCtD
Cilostazol—Myalgia—Methotrexate—lung cancer	7.04e-05	0.000276	CcSEcCtD
Cilostazol—Vomiting—Paclitaxel—lung cancer	7.03e-05	0.000275	CcSEcCtD
Cilostazol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	6.99e-05	0.000274	CcSEcCtD
Cilostazol—Rash—Paclitaxel—lung cancer	6.97e-05	0.000273	CcSEcCtD
Cilostazol—Dermatitis—Paclitaxel—lung cancer	6.96e-05	0.000273	CcSEcCtD
Cilostazol—Discomfort—Methotrexate—lung cancer	6.96e-05	0.000273	CcSEcCtD
Cilostazol—Back pain—Doxorubicin—lung cancer	6.93e-05	0.000272	CcSEcCtD
Cilostazol—Headache—Paclitaxel—lung cancer	6.92e-05	0.000271	CcSEcCtD
Cilostazol—Muscle spasms—Doxorubicin—lung cancer	6.89e-05	0.00027	CcSEcCtD
Cilostazol—Asthenia—Docetaxel—lung cancer	6.72e-05	0.000263	CcSEcCtD
Cilostazol—Infection—Methotrexate—lung cancer	6.71e-05	0.000263	CcSEcCtD
Cilostazol—Nausea—Etoposide—lung cancer	6.69e-05	0.000262	CcSEcCtD
Cilostazol—Ill-defined disorder—Doxorubicin—lung cancer	6.65e-05	0.000261	CcSEcCtD
Cilostazol—Pruritus—Docetaxel—lung cancer	6.63e-05	0.00026	CcSEcCtD
Cilostazol—Nervous system disorder—Methotrexate—lung cancer	6.62e-05	0.00026	CcSEcCtD
Cilostazol—Anaemia—Doxorubicin—lung cancer	6.62e-05	0.00026	CcSEcCtD
Cilostazol—Thrombocytopenia—Methotrexate—lung cancer	6.61e-05	0.000259	CcSEcCtD
Cilostazol—Nausea—Paclitaxel—lung cancer	6.56e-05	0.000257	CcSEcCtD
Cilostazol—Skin disorder—Methotrexate—lung cancer	6.56e-05	0.000257	CcSEcCtD
Cilostazol—Malaise—Doxorubicin—lung cancer	6.46e-05	0.000253	CcSEcCtD
Cilostazol—Vertigo—Doxorubicin—lung cancer	6.43e-05	0.000252	CcSEcCtD
Cilostazol—Anorexia—Methotrexate—lung cancer	6.43e-05	0.000252	CcSEcCtD
Cilostazol—Syncope—Doxorubicin—lung cancer	6.42e-05	0.000252	CcSEcCtD
Cilostazol—Leukopenia—Doxorubicin—lung cancer	6.41e-05	0.000251	CcSEcCtD
Cilostazol—Diarrhoea—Docetaxel—lung cancer	6.41e-05	0.000251	CcSEcCtD
Cilostazol—Palpitations—Doxorubicin—lung cancer	6.33e-05	0.000248	CcSEcCtD
Cilostazol—Hypotension—Methotrexate—lung cancer	6.31e-05	0.000247	CcSEcCtD
Cilostazol—Loss of consciousness—Doxorubicin—lung cancer	6.3e-05	0.000247	CcSEcCtD
Cilostazol—Cough—Doxorubicin—lung cancer	6.25e-05	0.000245	CcSEcCtD
Cilostazol—Dizziness—Docetaxel—lung cancer	6.19e-05	0.000243	CcSEcCtD
Cilostazol—Hypertension—Doxorubicin—lung cancer	6.18e-05	0.000242	CcSEcCtD
Cilostazol—Musculoskeletal discomfort—Methotrexate—lung cancer	6.15e-05	0.000241	CcSEcCtD
Cilostazol—Insomnia—Methotrexate—lung cancer	6.11e-05	0.000239	CcSEcCtD
Cilostazol—Chest pain—Doxorubicin—lung cancer	6.1e-05	0.000239	CcSEcCtD
Cilostazol—Arthralgia—Doxorubicin—lung cancer	6.1e-05	0.000239	CcSEcCtD
Cilostazol—Myalgia—Doxorubicin—lung cancer	6.1e-05	0.000239	CcSEcCtD
Cilostazol—Anxiety—Doxorubicin—lung cancer	6.08e-05	0.000238	CcSEcCtD
Cilostazol—Paraesthesia—Methotrexate—lung cancer	6.06e-05	0.000238	CcSEcCtD
Cilostazol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	6.06e-05	0.000237	CcSEcCtD
Cilostazol—Discomfort—Doxorubicin—lung cancer	6.02e-05	0.000236	CcSEcCtD
Cilostazol—Dyspnoea—Methotrexate—lung cancer	6.02e-05	0.000236	CcSEcCtD
Cilostazol—Vomiting—Docetaxel—lung cancer	5.96e-05	0.000233	CcSEcCtD
Cilostazol—Dyspepsia—Methotrexate—lung cancer	5.94e-05	0.000233	CcSEcCtD
Cilostazol—Rash—Docetaxel—lung cancer	5.91e-05	0.000232	CcSEcCtD
Cilostazol—Dermatitis—Docetaxel—lung cancer	5.9e-05	0.000231	CcSEcCtD
Cilostazol—Decreased appetite—Methotrexate—lung cancer	5.87e-05	0.00023	CcSEcCtD
Cilostazol—Headache—Docetaxel—lung cancer	5.87e-05	0.00023	CcSEcCtD
Cilostazol—Oedema—Doxorubicin—lung cancer	5.85e-05	0.000229	CcSEcCtD
Cilostazol—Gastrointestinal disorder—Methotrexate—lung cancer	5.83e-05	0.000229	CcSEcCtD
Cilostazol—Infection—Doxorubicin—lung cancer	5.81e-05	0.000228	CcSEcCtD
Cilostazol—Pain—Methotrexate—lung cancer	5.77e-05	0.000226	CcSEcCtD
Cilostazol—Shock—Doxorubicin—lung cancer	5.75e-05	0.000225	CcSEcCtD
Cilostazol—Nervous system disorder—Doxorubicin—lung cancer	5.73e-05	0.000225	CcSEcCtD
Cilostazol—Thrombocytopenia—Doxorubicin—lung cancer	5.72e-05	0.000224	CcSEcCtD
Cilostazol—Tachycardia—Doxorubicin—lung cancer	5.71e-05	0.000224	CcSEcCtD
Cilostazol—Skin disorder—Doxorubicin—lung cancer	5.68e-05	0.000223	CcSEcCtD
Cilostazol—Anorexia—Doxorubicin—lung cancer	5.57e-05	0.000218	CcSEcCtD
Cilostazol—Nausea—Docetaxel—lung cancer	5.56e-05	0.000218	CcSEcCtD
Cilostazol—Feeling abnormal—Methotrexate—lung cancer	5.56e-05	0.000218	CcSEcCtD
Cilostazol—Gastrointestinal pain—Methotrexate—lung cancer	5.52e-05	0.000216	CcSEcCtD
Cilostazol—Hypotension—Doxorubicin—lung cancer	5.46e-05	0.000214	CcSEcCtD
Cilostazol—Urticaria—Methotrexate—lung cancer	5.36e-05	0.00021	CcSEcCtD
Cilostazol—Abdominal pain—Methotrexate—lung cancer	5.34e-05	0.000209	CcSEcCtD
Cilostazol—Body temperature increased—Methotrexate—lung cancer	5.34e-05	0.000209	CcSEcCtD
Cilostazol—Musculoskeletal discomfort—Doxorubicin—lung cancer	5.33e-05	0.000209	CcSEcCtD
Cilostazol—Insomnia—Doxorubicin—lung cancer	5.29e-05	0.000207	CcSEcCtD
Cilostazol—Paraesthesia—Doxorubicin—lung cancer	5.25e-05	0.000206	CcSEcCtD
Cilostazol—Dyspnoea—Doxorubicin—lung cancer	5.21e-05	0.000204	CcSEcCtD
Cilostazol—Dyspepsia—Doxorubicin—lung cancer	5.15e-05	0.000202	CcSEcCtD
Cilostazol—Decreased appetite—Doxorubicin—lung cancer	5.08e-05	0.000199	CcSEcCtD
Cilostazol—Gastrointestinal disorder—Doxorubicin—lung cancer	5.05e-05	0.000198	CcSEcCtD
Cilostazol—Pain—Doxorubicin—lung cancer	5e-05	0.000196	CcSEcCtD
Cilostazol—Asthenia—Methotrexate—lung cancer	4.84e-05	0.00019	CcSEcCtD
Cilostazol—Feeling abnormal—Doxorubicin—lung cancer	4.82e-05	0.000189	CcSEcCtD
Cilostazol—Gastrointestinal pain—Doxorubicin—lung cancer	4.78e-05	0.000187	CcSEcCtD
Cilostazol—Pruritus—Methotrexate—lung cancer	4.78e-05	0.000187	CcSEcCtD
Cilostazol—Urticaria—Doxorubicin—lung cancer	4.64e-05	0.000182	CcSEcCtD
Cilostazol—Abdominal pain—Doxorubicin—lung cancer	4.62e-05	0.000181	CcSEcCtD
Cilostazol—Body temperature increased—Doxorubicin—lung cancer	4.62e-05	0.000181	CcSEcCtD
Cilostazol—Diarrhoea—Methotrexate—lung cancer	4.62e-05	0.000181	CcSEcCtD
Cilostazol—Dizziness—Methotrexate—lung cancer	4.46e-05	0.000175	CcSEcCtD
Cilostazol—Vomiting—Methotrexate—lung cancer	4.29e-05	0.000168	CcSEcCtD
Cilostazol—Rash—Methotrexate—lung cancer	4.26e-05	0.000167	CcSEcCtD
Cilostazol—Dermatitis—Methotrexate—lung cancer	4.25e-05	0.000167	CcSEcCtD
Cilostazol—Headache—Methotrexate—lung cancer	4.23e-05	0.000166	CcSEcCtD
Cilostazol—Asthenia—Doxorubicin—lung cancer	4.19e-05	0.000164	CcSEcCtD
Cilostazol—Pruritus—Doxorubicin—lung cancer	4.14e-05	0.000162	CcSEcCtD
Cilostazol—Nausea—Methotrexate—lung cancer	4.01e-05	0.000157	CcSEcCtD
Cilostazol—Diarrhoea—Doxorubicin—lung cancer	4e-05	0.000157	CcSEcCtD
Cilostazol—Dizziness—Doxorubicin—lung cancer	3.87e-05	0.000152	CcSEcCtD
Cilostazol—Vomiting—Doxorubicin—lung cancer	3.72e-05	0.000146	CcSEcCtD
Cilostazol—Rash—Doxorubicin—lung cancer	3.69e-05	0.000145	CcSEcCtD
Cilostazol—Dermatitis—Doxorubicin—lung cancer	3.68e-05	0.000144	CcSEcCtD
Cilostazol—Headache—Doxorubicin—lung cancer	3.66e-05	0.000144	CcSEcCtD
Cilostazol—Nausea—Doxorubicin—lung cancer	3.47e-05	0.000136	CcSEcCtD
Cilostazol—CYP2C19—Metabolism—GNG11—lung cancer	1.41e-05	0.000152	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—APOA1—lung cancer	1.4e-05	0.000151	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—ERBB2—lung cancer	1.4e-05	0.000151	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—TYMS—lung cancer	1.39e-05	0.00015	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—AKR1C1—lung cancer	1.38e-05	0.000149	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—MTOR—lung cancer	1.38e-05	0.000149	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—PIK3CB—lung cancer	1.38e-05	0.000149	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—GSTM1—lung cancer	1.37e-05	0.000148	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—CNDP2—lung cancer	1.36e-05	0.000147	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—GSTM2—lung cancer	1.36e-05	0.000147	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—UGT1A1—lung cancer	1.34e-05	0.000145	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—ALDOA—lung cancer	1.34e-05	0.000145	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—B4GALT5—lung cancer	1.34e-05	0.000144	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—MTMR3—lung cancer	1.32e-05	0.000143	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—CXCL8—lung cancer	1.32e-05	0.000143	CbGpPWpGaD
Cilostazol—PDE3A—Signaling by GPCR—HRAS—lung cancer	1.32e-05	0.000142	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—CYP2E1—lung cancer	1.31e-05	0.000141	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—GSTA4—lung cancer	1.3e-05	0.00014	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—NCOA3—lung cancer	1.3e-05	0.00014	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—CYP1A1—lung cancer	1.3e-05	0.00014	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—GNG11—lung cancer	1.29e-05	0.00014	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—NQO1—lung cancer	1.29e-05	0.00014	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—PGAM1—lung cancer	1.29e-05	0.000139	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—ERCC2—lung cancer	1.29e-05	0.000139	CbGpPWpGaD
Cilostazol—PDE3A—GPCR downstream signaling—AKT1—lung cancer	1.28e-05	0.000138	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	1.28e-05	0.000138	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	1.27e-05	0.000137	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—GSTA2—lung cancer	1.27e-05	0.000137	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—CASP3—lung cancer	1.27e-05	0.000137	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—ABCG2—lung cancer	1.27e-05	0.000136	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—ADCY1—lung cancer	1.27e-05	0.000136	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—IL2—lung cancer	1.27e-05	0.000136	CbGpPWpGaD
Cilostazol—PDE3A—Signaling by GPCR—IL6—lung cancer	1.26e-05	0.000136	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—ENO2—lung cancer	1.24e-05	0.000134	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—HPGDS—lung cancer	1.24e-05	0.000134	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—CCND1—lung cancer	1.23e-05	0.000133	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—PPP2R1B—lung cancer	1.23e-05	0.000133	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—ALDOA—lung cancer	1.23e-05	0.000133	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—CYP2A7—lung cancer	1.23e-05	0.000133	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—JUN—lung cancer	1.23e-05	0.000133	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—GSTA1—lung cancer	1.22e-05	0.000132	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—POMC—lung cancer	1.22e-05	0.000131	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—ABCC3—lung cancer	1.21e-05	0.00013	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—SDC4—lung cancer	1.21e-05	0.00013	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—GSTT1—lung cancer	1.2e-05	0.00013	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—MMP9—lung cancer	1.2e-05	0.000129	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—NCOA3—lung cancer	1.2e-05	0.000129	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—CDKN1A—lung cancer	1.19e-05	0.000129	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—PTEN—lung cancer	1.19e-05	0.000128	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—GCLC—lung cancer	1.19e-05	0.000128	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—CYP2A6—lung cancer	1.19e-05	0.000128	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	1.19e-05	0.000128	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—AKR1C1—lung cancer	1.17e-05	0.000126	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—STK11—lung cancer	1.17e-05	0.000126	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—ABCG2—lung cancer	1.16e-05	0.000126	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—ADCY1—lung cancer	1.16e-05	0.000126	CbGpPWpGaD
Cilostazol—PDE3A—Signaling by GPCR—AKT1—lung cancer	1.16e-05	0.000125	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—HPGDS—lung cancer	1.14e-05	0.000123	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—ENO2—lung cancer	1.14e-05	0.000123	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—UGT1A1—lung cancer	1.14e-05	0.000123	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—EP300—lung cancer	1.14e-05	0.000122	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—PPP2R1B—lung cancer	1.13e-05	0.000122	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—ENO1—lung cancer	1.13e-05	0.000122	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	1.12e-05	0.000121	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—APOA1—lung cancer	1.12e-05	0.00012	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—ALB—lung cancer	1.11e-05	0.00012	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—GSTT1—lung cancer	1.11e-05	0.000119	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—SRC—lung cancer	1.1e-05	0.000119	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—GSTA3—lung cancer	1.1e-05	0.000118	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—RRM1—lung cancer	1.1e-05	0.000118	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—GNG11—lung cancer	1.1e-05	0.000118	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—GCLC—lung cancer	1.09e-05	0.000118	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—CYP2A6—lung cancer	1.09e-05	0.000118	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—APOA1—lung cancer	1.09e-05	0.000118	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—GSTP1—lung cancer	1.08e-05	0.000116	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—VEGFA—lung cancer	1.08e-05	0.000116	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—STAT3—lung cancer	1.06e-05	0.000115	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—NRAS—lung cancer	1.06e-05	0.000115	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—CAT—lung cancer	1.05e-05	0.000113	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—ALDOA—lung cancer	1.04e-05	0.000113	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—ENO1—lung cancer	1.04e-05	0.000112	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—B4GALT5—lung cancer	1.03e-05	0.000111	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—ABCB1—lung cancer	1.02e-05	0.00011	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—PIK3CG—lung cancer	1.02e-05	0.00011	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—MAPK3—lung cancer	1.02e-05	0.00011	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—NCOA3—lung cancer	1.01e-05	0.000109	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—CYP2E1—lung cancer	1.01e-05	0.000109	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—GSTA4—lung cancer	1e-05	0.000108	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—TYMS—lung cancer	1e-05	0.000108	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—NQO1—lung cancer	1e-05	0.000108	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	9.96e-06	0.000107	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—GSTM1—lung cancer	9.92e-06	0.000107	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—MYC—lung cancer	9.89e-06	0.000107	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—ABCG2—lung cancer	9.86e-06	0.000106	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—ADCY1—lung cancer	9.86e-06	0.000106	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	9.8e-06	0.000106	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—GSTA2—lung cancer	9.79e-06	0.000106	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	9.71e-06	0.000105	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—POMC—lung cancer	9.7e-06	0.000105	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—EGFR—lung cancer	9.68e-06	0.000104	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—ENO2—lung cancer	9.67e-06	0.000104	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—HPGDS—lung cancer	9.67e-06	0.000104	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—PPP2R1B—lung cancer	9.61e-06	0.000104	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—POMC—lung cancer	9.48e-06	0.000102	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—CREBBP—lung cancer	9.45e-06	0.000102	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—GSTA1—lung cancer	9.44e-06	0.000102	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—CYP1A1—lung cancer	9.4e-06	0.000101	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—GSTT1—lung cancer	9.38e-06	0.000101	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—ABCC3—lung cancer	9.34e-06	0.000101	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—ERCC2—lung cancer	9.32e-06	0.000101	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—CYP2E1—lung cancer	9.3e-06	0.0001	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—CYP2A6—lung cancer	9.27e-06	0.0001	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—GCLC—lung cancer	9.27e-06	0.0001	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	9.23e-06	9.96e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—NQO1—lung cancer	9.2e-06	9.92e-05	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—KRAS—lung cancer	9.14e-06	9.86e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—AKR1C1—lung cancer	9.04e-06	9.75e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—STK11—lung cancer	9.02e-06	9.72e-05	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—PIK3CD—lung cancer	8.96e-06	9.66e-05	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—ALB—lung cancer	8.84e-06	9.53e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—ENO1—lung cancer	8.79e-06	9.48e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—UGT1A1—lung cancer	8.78e-06	9.46e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	8.76e-06	9.44e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—ALB—lung cancer	8.64e-06	9.32e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—lung cancer	8.46e-06	9.13e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—GNG11—lung cancer	8.46e-06	9.13e-05	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—PIK3CA—lung cancer	8.4e-06	9.06e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—GSTP1—lung cancer	8.34e-06	9e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—STK11—lung cancer	8.29e-06	8.94e-05	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—TP53—lung cancer	8.13e-06	8.76e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—CAT—lung cancer	8.12e-06	8.76e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—EP300—lung cancer	8.07e-06	8.7e-05	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—APOA1—lung cancer	8.07e-06	8.7e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—ALDOA—lung cancer	8.06e-06	8.69e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—ABCB1—lung cancer	7.9e-06	8.52e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—CYP2E1—lung cancer	7.88e-06	8.5e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—NCOA3—lung cancer	7.82e-06	8.44e-05	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—PIK3CB—lung cancer	7.81e-06	8.42e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—NQO1—lung cancer	7.79e-06	8.41e-05	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—HRAS—lung cancer	7.77e-06	8.38e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—TYMS—lung cancer	7.76e-06	8.36e-05	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—PTGS2—lung cancer	7.73e-06	8.34e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—GSTP1—lung cancer	7.67e-06	8.28e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—GSTM1—lung cancer	7.67e-06	8.27e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	7.63e-06	8.23e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—ADCY1—lung cancer	7.61e-06	8.21e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—ABCG2—lung cancer	7.61e-06	8.21e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	7.56e-06	8.16e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—CAT—lung cancer	7.47e-06	8.05e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—HPGDS—lung cancer	7.46e-06	8.05e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—ENO2—lung cancer	7.46e-06	8.05e-05	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—IL6—lung cancer	7.44e-06	8.02e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—PPP2R1B—lung cancer	7.42e-06	8e-05	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—PIK3CG—lung cancer	7.36e-06	7.94e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—CYP1A1—lung cancer	7.27e-06	7.84e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—ABCB1—lung cancer	7.26e-06	7.83e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—GSTT1—lung cancer	7.24e-06	7.81e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—ERCC2—lung cancer	7.21e-06	7.77e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—GCLC—lung cancer	7.15e-06	7.72e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—CYP2A6—lung cancer	7.15e-06	7.72e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—TYMS—lung cancer	7.13e-06	7.69e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—GSTM1—lung cancer	7.05e-06	7.6e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—STK11—lung cancer	7.03e-06	7.58e-05	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—POMC—lung cancer	7.01e-06	7.56e-05	CbGpPWpGaD
Cilostazol—PDE3A—Signaling Pathways—AKT1—lung cancer	6.86e-06	7.4e-05	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—CREBBP—lung cancer	6.83e-06	7.36e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—ENO1—lung cancer	6.78e-06	7.31e-05	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—PTEN—lung cancer	6.75e-06	7.27e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—CYP1A1—lung cancer	6.69e-06	7.21e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—ERCC2—lung cancer	6.63e-06	7.15e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—lung cancer	6.6e-06	7.11e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—GSTP1—lung cancer	6.5e-06	7.01e-05	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—PIK3CD—lung cancer	6.47e-06	6.98e-05	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—EP300—lung cancer	6.43e-06	6.94e-05	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—ALB—lung cancer	6.39e-06	6.89e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—CAT—lung cancer	6.33e-06	6.82e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—EP300—lung cancer	6.29e-06	6.78e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—APOA1—lung cancer	6.24e-06	6.72e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—ABCB1—lung cancer	6.15e-06	6.64e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—CYP2E1—lung cancer	6.08e-06	6.56e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—TYMS—lung cancer	6.04e-06	6.52e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—NQO1—lung cancer	6.02e-06	6.49e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—GSTM1—lung cancer	5.97e-06	6.44e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	5.97e-06	6.44e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—APOA1—lung cancer	5.74e-06	6.19e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—PIK3CG—lung cancer	5.69e-06	6.14e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—CYP1A1—lung cancer	5.66e-06	6.11e-05	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—PIK3CB—lung cancer	5.64e-06	6.08e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—ERCC2—lung cancer	5.62e-06	6.06e-05	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—PTGS2—lung cancer	5.59e-06	6.03e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—STK11—lung cancer	5.42e-06	5.85e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—POMC—lung cancer	5.42e-06	5.84e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—CREBBP—lung cancer	5.28e-06	5.69e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—PIK3CG—lung cancer	5.24e-06	5.65e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—GSTP1—lung cancer	5.02e-06	5.41e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—PIK3CD—lung cancer	5e-06	5.4e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—POMC—lung cancer	4.98e-06	5.38e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—ALB—lung cancer	4.94e-06	5.33e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—CAT—lung cancer	4.88e-06	5.26e-05	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—PTEN—lung cancer	4.88e-06	5.26e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—APOA1—lung cancer	4.86e-06	5.24e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—CREBBP—lung cancer	4.85e-06	5.24e-05	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—PIK3CA—lung cancer	4.76e-06	5.13e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—ABCB1—lung cancer	4.75e-06	5.12e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—TYMS—lung cancer	4.66e-06	5.03e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	4.65e-06	5.02e-05	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—EP300—lung cancer	4.65e-06	5.01e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—GSTM1—lung cancer	4.61e-06	4.97e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—PIK3CD—lung cancer	4.6e-06	4.96e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—ALB—lung cancer	4.54e-06	4.9e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—PIK3CG—lung cancer	4.44e-06	4.78e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—CYP1A1—lung cancer	4.37e-06	4.71e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—PIK3CB—lung cancer	4.36e-06	4.7e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—ERCC2—lung cancer	4.33e-06	4.67e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—PTGS2—lung cancer	4.32e-06	4.66e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—POMC—lung cancer	4.22e-06	4.55e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—CREBBP—lung cancer	4.11e-06	4.44e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—PIK3CB—lung cancer	4.01e-06	4.33e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—PTGS2—lung cancer	3.98e-06	4.29e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—PIK3CD—lung cancer	3.9e-06	4.21e-05	CbGpPWpGaD
Cilostazol—CYP3A7—Metabolism—AKT1—lung cancer	3.89e-06	4.19e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—ALB—lung cancer	3.85e-06	4.15e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—PTEN—lung cancer	3.77e-06	4.07e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—APOA1—lung cancer	3.75e-06	4.04e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—EP300—lung cancer	3.59e-06	3.88e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—PTEN—lung cancer	3.47e-06	3.74e-05	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—PIK3CA—lung cancer	3.44e-06	3.71e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—PIK3CG—lung cancer	3.42e-06	3.69e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—PIK3CB—lung cancer	3.4e-06	3.67e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—PTGS2—lung cancer	3.37e-06	3.63e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—EP300—lung cancer	3.31e-06	3.57e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—POMC—lung cancer	3.26e-06	3.51e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—CREBBP—lung cancer	3.17e-06	3.42e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—PIK3CD—lung cancer	3.01e-06	3.25e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—ALB—lung cancer	2.97e-06	3.2e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—PTEN—lung cancer	2.94e-06	3.17e-05	CbGpPWpGaD
Cilostazol—CYP3A5—Metabolism—AKT1—lung cancer	2.81e-06	3.03e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—EP300—lung cancer	2.8e-06	3.02e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—PIK3CA—lung cancer	2.66e-06	2.87e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—PIK3CB—lung cancer	2.62e-06	2.83e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—PTGS2—lung cancer	2.6e-06	2.8e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—PIK3CA—lung cancer	2.45e-06	2.64e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—PTEN—lung cancer	2.27e-06	2.44e-05	CbGpPWpGaD
Cilostazol—CYP2C19—Metabolism—AKT1—lung cancer	2.17e-06	2.34e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—EP300—lung cancer	2.16e-06	2.33e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—PIK3CA—lung cancer	2.07e-06	2.23e-05	CbGpPWpGaD
Cilostazol—CYP2D6—Metabolism—AKT1—lung cancer	2e-06	2.15e-05	CbGpPWpGaD
Cilostazol—CYP1A2—Metabolism—AKT1—lung cancer	1.69e-06	1.83e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—PIK3CA—lung cancer	1.6e-06	1.72e-05	CbGpPWpGaD
Cilostazol—CYP3A4—Metabolism—AKT1—lung cancer	1.31e-06	1.41e-05	CbGpPWpGaD
